Thomas Dixon-McDougall, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heterochromatin | 3 | 2022 | 294 | 0.830 |
Why?
|
| Histones | 3 | 2022 | 2600 | 0.700 |
Why?
|
| X Chromosome Inactivation | 3 | 2018 | 229 | 0.660 |
Why?
|
| Gene Silencing | 5 | 2022 | 1505 | 0.570 |
Why?
|
| Sex Chromatin | 1 | 2015 | 19 | 0.510 |
Why?
|
| X Chromosome | 2 | 2018 | 819 | 0.410 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3443 | 0.330 |
Why?
|
| Chromosomes, Human, X | 3 | 2021 | 320 | 0.320 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 11930 | 0.210 |
Why?
|
| Organic Cation Transporter 1 | 1 | 2021 | 8 | 0.190 |
Why?
|
| Stilbenes | 1 | 2021 | 155 | 0.180 |
Why?
|
| Mammals | 2 | 2023 | 1136 | 0.170 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2021 | 781 | 0.160 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2022 | 633 | 0.140 |
Why?
|
| Sequence Deletion | 1 | 2021 | 1494 | 0.130 |
Why?
|
| DNA Methylation | 3 | 2023 | 4426 | 0.130 |
Why?
|
| Oncogenes | 1 | 2021 | 1232 | 0.120 |
Why?
|
| Acetylation | 1 | 2015 | 1055 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 1888 | 0.090 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 717 | 0.090 |
Why?
|
| Chromatin | 1 | 2022 | 2981 | 0.080 |
Why?
|
| Receptors, Nicotinic | 1 | 2013 | 494 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2013 | 943 | 0.080 |
Why?
|
| Protein Binding | 1 | 2021 | 9343 | 0.080 |
Why?
|
| Nicotine | 1 | 2013 | 680 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 5799 | 0.070 |
Why?
|
| Cell Line | 1 | 2021 | 15597 | 0.070 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2013 | 881 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2013 | 1862 | 0.060 |
Why?
|
| Models, Biological | 1 | 2021 | 9493 | 0.060 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 1472 | 0.050 |
Why?
|
| Mice | 3 | 2022 | 82024 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 3834 | 0.050 |
Why?
|
| Animals | 5 | 2023 | 169222 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2021 | 858 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 9614 | 0.040 |
Why?
|
| Genes, X-Linked | 1 | 2018 | 129 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 2018 | 373 | 0.040 |
Why?
|
| Humans | 7 | 2023 | 767991 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 21206 | 0.030 |
Why?
|
| Mecamylamine | 1 | 2013 | 27 | 0.030 |
Why?
|
| Butanones | 1 | 2013 | 23 | 0.030 |
Why?
|
| Nicotinic Antagonists | 1 | 2013 | 94 | 0.030 |
Why?
|
| Taste | 1 | 2013 | 190 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2013 | 277 | 0.020 |
Why?
|
| Nicotinic Agonists | 1 | 2013 | 265 | 0.020 |
Why?
|
| Quinoxalines | 1 | 2013 | 297 | 0.020 |
Why?
|
| Benzazepines | 1 | 2013 | 308 | 0.020 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2013 | 471 | 0.020 |
Why?
|
| Chlorides | 1 | 2013 | 666 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 5798 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2013 | 600 | 0.020 |
Why?
|
| Muscles | 1 | 2013 | 1582 | 0.020 |
Why?
|
| Sodium | 1 | 2013 | 1597 | 0.020 |
Why?
|
| Fasting | 1 | 2013 | 1609 | 0.020 |
Why?
|
| Reward | 1 | 2013 | 981 | 0.020 |
Why?
|
| Female | 4 | 2021 | 397113 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8637 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 17128 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3612 | 0.010 |
Why?
|
| Aging | 1 | 2023 | 8744 | 0.010 |
Why?
|
| Genome, Human | 1 | 2015 | 4443 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13658 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18407 | 0.010 |
Why?
|
| Neurons | 1 | 2013 | 9518 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 40214 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 30211 | 0.000 |
Why?
|
| Male | 1 | 2018 | 364641 | 0.000 |
Why?
|